Meeder Asset Management Inc Surface Oncology, Inc. Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$1.57 - $6.56 $891 - $3,726	-568 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.44 - $3.95 $5,605 - $15,377	-3,893 Reduced 87.27%	568 $1,000
Q4 2019 Feb 13, 2020	SELL	$1.17 - $2.33 $340 - $678	-291 Reduced 6.12%	4,461 $8,000
Q3 2019 Oct 17, 2019	BUY	$1.4 - $2.84 $4,873 - $9,886	3,481 Added 273.88%	4,752 $7,000
Q2 2019 Aug 05, 2019	SELL	$2.75 - $4.89 $15,048 - $26,758	-5,472 Reduced 81.15%	1,271 $4,000
Q1 2019 Apr 16, 2019	SELL	$4.11 - $5.88 $464 - $664	-113 Reduced 1.65%	6,743 $33,000
Q4 2018 Jan 17, 2019	BUY	$3.65 - $10.69 $25,024 - $73,290	6,856 New	6,856 $30,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.